Science And TechnologyGS3-Science And Technology
India Launches Indigenous Antibiotic Nafithromycin
India launched its first indigenous antibiotic, Nafithromycin, to combat drug-resistant infections.
November 21, 2024
Key Points
- 1The antibiotic Nafithromycin has been developed with the support of BIRAC.
- 2It is brought to market under the trade name "Miqnaf" by pharma company "Wolkardt".
- 3It is designed to treat Community-Acquired Bacterial Pneumonia (CABP).
- 4The three-day treatment regimen of Nafithromycin is a game-changer.
- 5Nafithromycin is ten times more effective than azithromycin.
- 6The development of Nafithromycin represents 14 years of dedicated research and an investment of ₹500 crores.
Important Terms
NafithromycinAntibioticAMRBIRACWockhardt
UPSC Current Affairs
Last Updated: 7/4/2025